Treatment and Prevention of Heparin-Induced Thrombocytopenia
Lori‐Ann Linkins(McMaster University), Mark Crowther(Population Health Research Institute), Bruce L. Davidson(University of Washington), Robert Bona(Quinnipiac University), Sam Schulman(Thrombosis and Atherosclerosis Research Institute), Antonio L. Dans(University of the Philippines Manila), Lisa K. Moores(Uniformed Services University of the Health Sciences)
Cited by 1,010
Related Papers
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients
|Journal of Thrombosis and Haemostasis|2005|4.9k
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients
|Journal of Thrombosis and Haemostasis|2009|3.8k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Prevention of VTE in Nonsurgical Patients
|CHEST Journal|2012|2.7k
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
|New England Journal of Medicine|2009|2.6k